chr7-141972854-A-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_176817.5(TAS2R38):c.836T>A(p.Val279Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,756 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_176817.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAS2R38 | NM_176817.5 | c.836T>A | p.Val279Glu | missense_variant | 1/1 | ENST00000547270.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAS2R38 | ENST00000547270.1 | c.836T>A | p.Val279Glu | missense_variant | 1/1 | NM_176817.5 | P1 | ||
MGAM | ENST00000465654.5 | c.-3+26857A>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000593 AC: 9AN: 151754Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251028Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135648
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461884Hom.: 1 Cov.: 70 AF XY: 0.0000138 AC XY: 10AN XY: 727244
GnomAD4 genome AF: 0.0000593 AC: 9AN: 151872Hom.: 0 Cov.: 31 AF XY: 0.0000808 AC XY: 6AN XY: 74212
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2023 | The c.836T>A (p.V279E) alteration is located in exon 1 (coding exon 1) of the TAS2R38 gene. This alteration results from a T to A substitution at nucleotide position 836, causing the valine (V) at amino acid position 279 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at